DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 70 filers reported holding DERMA SCIENCES INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $295,000 | +15.7% | 56,718 | +3.9% | 0.00% | – |
| Q3 2016 | $255,000 | +18.6% | 54,602 | +0.2% | 0.00% | – |
| Q2 2016 | $215,000 | +25.0% | 54,495 | -1.5% | 0.00% | – |
| Q1 2016 | $172,000 | -36.5% | 55,351 | -6.8% | 0.00% | – |
| Q4 2015 | $271,000 | +1.9% | 59,387 | +5.3% | 0.00% | – |
| Q3 2015 | $266,000 | -35.7% | 56,380 | -2.6% | 0.00% | – |
| Q2 2015 | $414,000 | -92.1% | 57,868 | -90.7% | 0.00% | -100.0% |
| Q1 2015 | $5,246,000 | -8.8% | 619,345 | +0.3% | 0.00% | 0.0% |
| Q4 2014 | $5,751,000 | +29.5% | 617,699 | +15.8% | 0.00% | 0.0% |
| Q3 2014 | $4,442,000 | -31.8% | 533,251 | -5.4% | 0.00% | -50.0% |
| Q2 2014 | $6,515,000 | -5.9% | 563,597 | +3.2% | 0.00% | 0.0% |
| Q1 2014 | $6,925,000 | +68.7% | 546,159 | +43.9% | 0.00% | +100.0% |
| Q4 2013 | $4,106,000 | -15.9% | 379,512 | -3.8% | 0.00% | -50.0% |
| Q3 2013 | $4,884,000 | +3.8% | 394,522 | +11.9% | 0.00% | 0.0% |
| Q2 2013 | $4,706,000 | – | 352,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 373,918 | $2,677,000 | 2.26% |
| Perceptive Advisors | 348,784 | $24,997,000 | 1.50% |
| Consonance Capital Management LP | 1,760,649 | $12,606,000 | 1.27% |
| Broadfin Capital, LLC | 2,317,489 | $16,593,000 | 0.89% |
| GREAT POINT PARTNERS LLC | 280,000 | $2,005,000 | 0.78% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 300,000 | $2,148,000 | 0.75% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 273,926 | $1,961,000 | 0.63% |
| Senvest Management, LLC | 1,152,626 | $8,253,000 | 0.52% |
| J. Goldman & Co LP | 622,500 | $4,457,000 | 0.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 968,881 | $6,937,000 | 0.23% |